Literature DB >> 20075601

Association between non-high-density lipoprotein cholesterol concentrations and mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study.

Hiroyuki Noda1, Hiroyasu Iso, Fujiko Irie, Toshimi Sairenchi, Emiko Ohtaka, Hitoshi Ohta.   

Abstract

AIM: The aim of this study was to examine whether non-high-density lipoprotein cholesterol (non-HDL-cholesterol) raises the risk of coronary heart disease in a dose-response fashion in a non-obese population with low total cholesterol levels and high HDL-cholesterol levels, such as Japanese.
METHODS: A total of 30,802 men and 60,417 women, aged 40 to 79 years with no history of stroke or coronary heart disease, completed a baseline risk factor survey in 1993 under the auspices of the Ibaraki Prefectural Health Study. Systematic mortality surveillance through 2003 identified 539 coronary heart disease deaths.
RESULTS: The mean values for non-HDL-cholesterol were 140 mg/dL for men and 151 mg/dL for women. The corresponding mean values were 193 mg/dL and 208 mg/dL total cholesterol and 52 mg/dL and 57 mg/dL HDL-cholesterol, respectively. Men with non-HDL-cholesterol > or = 180 mg/dL had a two-fold higher age-adjusted risk of mortality from coronary heart disease than did those with non-HDL-cholesterol <100 mg/dL, whereas no such association was found for women. The multivariable hazard ratio for > or = 180 mg/dL versus <100 mg/dL of non-HDL-cholesterol was 2.22 (95% confidence interval: 1.37 to 3.62) for men and 0.71 (0.37 to 1.34) for women.
CONCLUSION: Higher concentrations of non-HDL-cholesterol were associated with an increased risk of mortality from coronary heart disease for men, but not for women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075601     DOI: 10.5551/jat.1016

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  11 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients.

Authors:  Masaki Hara; Naoki Yanagisawa; Akihito Ohta; Kumiko Momoki; Ken Tsuchiya; Kosaku Nitta; Minoru Ando
Journal:  Clin Exp Nephrol       Date:  2016-05-18       Impact factor: 2.801

Review 3.  Cardiovascular disease, a major global burden: Epidemiology of stroke and ischemic heart disease in Japan.

Authors:  Hiroyasu Iso
Journal:  Glob Health Med       Date:  2021-12-31

4.  Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?

Authors:  Esther Ching-Lan Lin; Wen-Chuan Shao; Hsin-Ju Yang; Miaofen Yen; Sheng-Yu Lee; Pei-Chun Wu; Ru-Band Lu
Journal:  Metab Brain Dis       Date:  2014-07-19       Impact factor: 3.584

5.  Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study.

Authors:  Chaoyang Li; Earl S Ford; James Tsai; Guixiang Zhao; Lina S Balluz; Samuel S Gidding
Journal:  Cardiovasc Diabetol       Date:  2011-05-23       Impact factor: 9.951

6.  Relationship Between Non-fasting Triglycerides and Cardiovascular Disease Mortality in a 20-year Follow-up Study of a Japanese General Population: NIPPON DATA90.

Authors:  Aya Hirata; Tomonori Okamura; Takumi Hirata; Daisuke Sugiyama; Takayoshi Ohkubo; Nagako Okuda; Yoshikuni Kita; Takehito Hayakawa; Aya Kadota; Keiko Kondo; Katsuyuki Miura; Akira Okayama; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2021-06-22       Impact factor: 3.809

Review 7.  Atherosclerotic Cardiovascular Risk in Japan.

Authors:  Shuko Nojiri; Hiroyuki Daida
Journal:  Jpn Clin Med       Date:  2017-06-19

8.  Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study.

Authors:  Isao Saito; Kazumasa Yamagishi; Yoshihiro Kokubo; Hiroshi Yatsuya; Hiroyasu Iso; Norie Sawada; Manami Inoue; Shoichiro Tsugane
Journal:  J Atheroscler Thromb       Date:  2019-09-19       Impact factor: 4.928

9.  Long-Term Exposure to Particulate Matter and Mortality from Cardiovascular Diseases in Japan: The Ibaraki Prefectural Health Study (IPHS).

Authors:  Ayano Takeuchi; Yuji Nishiwaki; Tomonori Okamura; Ai Milojevic; Kayo Ueda; Keiko Asakura; Toru Takebayashi; Shuichi Hasegawa; Toshimi Sairenchi; Fujiko Irie; Hitoshi Ota; Hiroshi Nitta
Journal:  J Atheroscler Thromb       Date:  2020-07-08       Impact factor: 4.928

10.  Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study.

Authors:  Ichiro Komiya; Akira Yamamoto; Suguru Sunakawa; Tamio Wakugami
Journal:  Lipids Health Dis       Date:  2021-02-20       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.